Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer.

Trial Profile

Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs Patupilone (Primary)
  • Indications Advanced breast cancer; Cancer metastases; Male breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jun 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov
    • 25 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Apr 2011 Planned End Date changed from 1 Jun 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top